 |
 |
+++++++++++++++++++++++++++++++++++++++++++++++++ Posted Wed, 2 Dec 2015 08:02:12 This message was forwarded through MEDSOCNEWS. If you wish to make an announcement or publicise an event then please send the text to: [log in to unmask] You can follow us on twitter @MedSocNews +++++++++++++++++++++++++++++++++++++++++++++++++ Call for registration: The redefinition of Alzheimer’s disease and its social and ethical consequences Fondation Brocher, Geneva, April 14-15 2015 The symposium brings together social scientists, ethicists, scientists and clinicians to examine the scientific practices associated with the recent redefinition of the diagnostic criteria for Alzheimer’s disease and the concomitant emphasis on the need to identify and intervene in neurodegenerative processes at an earlier stage. The symposium explores the boundary between the clinical and research uses of biomarkers and how, as the shifting boundary been laboratory and clinic, and normal and pathological ageing changes how we study, care for and, as a society, approach Alzheimer’s disease. Symposium sessions explore three key dimensions of the redefinition of Alzheimer’s disease, featuring empirical and theoretical papers presenting work conducted on Alzheimer’s disease and cognate areas. 1. The ethical, legal and social implications of preclinical disease states 2. The translational challenges of biomarker-based diagnostic criteria 3. Biomarkers, the normal and the pathological Confirmed speakers include: Carol Brayne (University of Cambridge) Joanna Latimer (University of Cardiff) Marianne Boenink (University of Twente) Alex Hillman (University of Cardiff) Annette Leibing (University of Montreal) Marion Droz Mendelzweig (University of Lausanne) Tiago Moreira (University of Durham) Vincent Pidoux (University of Lausanne) Pamela Sankar (University of Pennsylvania) Silke Schicktanz (University of Gottingen) Registration 150CHF/€140 at http://brocher.ch/fr/events/239/the-redefinition-of-alzheimer-s-disease-and-its-social-and-ethical-consequences Organised by Richard Milne and Shirlene Badger (University of Cambridge) and Jason Karlawish (University of Pennsylvania) For more information, contact Richard Milne ([log in to unmask]<mailto:[log in to unmask]>) Dr Richard Milne Research Associate Institute of Public Health University of Cambridge ********************************************************************** 1. For general enquires or problems with the list or to CHANGE YOUR EMAIL ADDRESS send a message to: [log in to unmask] 2. To suspend yourself from the list, whilst on leave, for example, send an email to [log in to unmask] with the following message: set medsocnews nomail 3. To resume email from the list, send the following message: set medsocnews mail 4. To leave MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature): leave medsocnews 5. To join or subscribe to MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature): SUBSCRIBE medsocnews firstname lastname 6. Further information about the medsocnews discussion list (including list archive and how to subscribe to or leave the list) can be found at the list web site: http://www.jiscmail.ac.uk/lists/medsocnews.html **********************************************************************